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Abstract
Aims/hypothesis Pw1 or paternally-expressed gene 3 (Peg3)
encodes a zinc finger transcription factor that is widely
expressed during mouse embryonic development and later
restricted to multiple somatic stem cell lineages in the adult.
The aim of the present study was to define Pw1 expression in
the embryonic and adult pancreas and investigate its role in the
beta cell cycle in Pw1 wild-type and mutant mice.
Methods We analysed PW1 expression by immunohisto-
chemistry in pancreas of nonpregant and pregnant mice and
following injury by partial duct ligation. Its role in the beta cell
cycle was studied in vivo using a novel conditional knockout
mouse and in vitro by lentivirus-mediated gene knockdown.
Results We showed that PW1 is expressed in early pancreatic
progenitors at E9.5 but becomes progressively restricted to
fully differentiated beta cells as they become established after
birth and withdraw from the cell cycle. Notably, PW1 expres-
sion declines when beta cells are induced to proliferate and
loss of PW1 function activates the beta cell cycle.
Conclusions/interpretation These results indicate that PW1 is
a co-regulator of the beta cell cycle and can thus be considered
a novel therapeutic target in diabetes.







PDL Partial duct ligation
PDX1 Pancreatic and duodenal homeobox 1
PTF1A Pancreas-specific transcription factor 1a
Sh Short hairpin
Introduction
Under physiological conditions, beta cell division declines
continuously after birth in both humans and rodents [1]. In
response to increased metabolic demand such as obesity or
pregnancy, beta cells can undergo hyperplasia and hypertro-
phy suggesting that their innate capacity to divide is not lost in
the adult [2].
The Pw1 (also known asPeg3) parentally imprinted gene is
unique to placental mammals and encodes a large protein
containing a Krüppel-type zinc finger [3, 4]. Chromatin
immunoprecipitation sequencing analyses have shown that
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PW1 controls multiple genes that regulate the cell cycle and/or
cellular metabolism [5–7]. Furthermore, in vitro studies have
shown that PW1 mediates p53–Bax signalling in the p53
growth arrest and cell death pathway activated by DNA
damage, possibly by interacting with Siah1 to induce Bax
translocation to the mitochondria [8–10]. Consistent with these
in vitro studies, loss of Pw1 expression correlates with in-
creased cell proliferation and tumour grade in gynaecological
and glioma cell lines [6, 7, 11]. Taken together, these studies
suggest that PW1 acts as a cell cycle inhibitor and tumour
suppressor in multiple cell types. However, Pw1 expression,
while widespread during early mouse embryonic develop-
ment [4], is progressively downregulated in most tissues
during late embryonic and fetal development. At these stages,
high levels of expression are restricted to adult somatic stem
cells in several tissues, including skeletal muscle, gut, hair
follicles, the central nervous system and bone marrow [12].
The ‘pan-stem cell’ pattern of Pw1 expression in the adult
prompted us to examine its expression in the pancreas during
embryonic development and adulthood.
Methods
Mice All animal experiments were approved by our insti-
tutional Ethical Committee for Animal Experiments and
followed national guidelines and regulations. BALB/c
adult and timed pregnant mice were purchased from Janvier
Labs (St Berthevin, France). Male C57BL/6 mice of 8 weeks
old underwent partial duct ligation (PDL) surgery, as pre-
viously described [13]. We generated a new mouse strain
with a novel conditional allele, Pw1+/lox. Male Pw1+/pat−mice
(F3) were crossed with C57BL/6 female mice (Janvier Lab) to
obtain age-matched paternal knockout and wild-type litter-
mates. Four to six mice per cage were maintained under a
12 h light/dark cycle at 24°C and fed a standard diet ad
libitum. PgkCre, Ptf1aCre Ngn3YFP and Ngn3−/− strains were
described previously [14–16]. These transgenic mice had
mixed genetic backgrounds.
Immunostaining and image analysis Tissue sections and
cultured cells were processed for immunostaining as pre-
viously described [17]. Sections were incubated overnight
at 4°C with primary antibodies (electronic supplementary
material [ESM] Table 1) diluted in 0.2% normal donkey
serum containing 0.01% Triton X-100. Cyanine- or
DyLight-labelled secondary antibodies were obtained from
Jackson ImmunoResearch (Newmarket, UK). The total beta
cell volume was analysed as previously described [17–19].
Images were captured with an inverted microscope (Nikon
Instruments, Amstelveen, the Netherlands) equipped with a
Hamamatsu digital camera c10600 (Olympus, Tokyo, Japan)
or with a multiphoton microscope (Zeiss LSM710 NLO with
a TiSa laser, NY, USA) and analysed using Smartcapture 3
(version 3.0.8) NIS AR2.30 Imaging Software (Nikon France,
Champigny-sur-Marne, France) or Improvision Volocity LE
(version 5.0) (PerkinElmer, Waltham, MA, USA) and ImageJ
software (https://imagej.nih.gov/ij/) [20].
Lentivirus-mediated gene knockdown A Pw1 targeting
sequence (5′-GAGTCGCAGTCAATCGATT-3′), loop sequence
(5′-TTCAAGAGA-3′) and its reverse complement were
annealed and cloned into the BglII and HindIII sites of the
pSuper.basic vector. Insert-containing clones were selected
by PCR and verified by sequencing. Next, an EcoRI–SalI
fragment containing the H1 promoter and the cloned oligo
duplex was subcloned into the BamHI–ClaI sites of the
pTripGFP vector and co-transfected with the pMD2g and
pCMVΔ8.4 plasmids into 293 T cells, as described previously
[21].Viral vectorswere obtained fromP.Ravassard (ICM - Institut
du Cerveau et de la Moelle épinière, Hôpital Pitié-Salpêtrière,
Paris, France) and 293 T cells from ATCC (LGC Standards,
Molsheim Cedex, France). Viruses were collected from the
culturemedium, filtered and concentrated by ultracentrifugation.
RNA analysis Total RNA isolation, amplification and
normalisation of data were done as previously described
[17]. Primer and probe sequences for quantitative PCR are
presented in ESM Table 2.
Statistical analysis Data are expressed as the means ± SEM
of at least three independent experiments and analysed by
unpaired two-tailed Student’s t test or two-way and one-way
ANOVA followed by Tukey’s honest significant difference
post hoc testing. A p value of <0.05 was considered statisti-
cally significant. Sample sizes are shown in the figure legends.
Results
PW1 expression in the pancreas of embryonic and adult
mice During the primary transition phase of the developing
mouse pancreas (embryonic day [E]9.5–E11.5), PW1 is
detected in the nuclei of pancreatic and duodenal homeobox
1 (PDX1)+ progenitor cells (Fig. 1a). Glucagon-expressing
(GCG+) cells are generated during this period and most
contain high levels of PW1 throughout gestation
(Fig. 1a, b). In contrast, the number of insulin-expressing
(INS+) cells that express PW1 progressively increases
during embryonic development (Fig. 1c). During the secondary
transition phase (E13.5–E15.5), the number of PW1+ PDX1+
cells decreases and most PW1 is found in cells lining and
near to the exocrine ducts at sites where endocrine pro-
genitor cells become specified (ESM Fig. 1a–c). In addition,
in pancreases ofNgn3 knockout mice that lack endocrine cells
[14], PW1+ cells were present in both mutant and wild-type
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littermates at an early stage of pancreatic development
(E11.5–E14.5) but absent after endocrine specification
(at E17 and later) in Ngn3 knockout mice (ESM Fig. 1d). In
the adult pancreas (at 8 weeks old), PW1 was abundant in
most beta cells (only 4.64 ± 0.35% of INS+ cells were
PW1−) and alpha cells (Fig. 1d) but also in somatostatin+ delta
cells and pancreatic polypeptide+ cells (data not shown). We
conclude that PW1 is expressed in all pancreatic progenitors
before endocrine specification and primarily in the endocrine
cells after specification.
PW1 restrains the beta cell cycle As PW1 is involved in
growth arrest in several cell types, we investigated its presence
in cycling beta cells. In the pancreases of embryonic mice at
E14.5 and E17.5, as well as in newborn mice, most actively
cycling beta cells do not express PW1 (Fig. 2a). In 8-week-old
mice, 0.79±0.17% of all INS+ cells were Ki67+; of these, 59
± 8% were PW1−. The number of PW1+ beta cells in the
pancreases of 8-week-old mice is 4% higher than in postnatal
day 1 (P1) and 14% higher than in P5. In adult mice, beta cell
proliferation can be activated by pregnancy [2] or in response
to injury by PDL [22]. The abundance of Pw1 mRNA was
decreased in islets from mice at gestation day 15 compared
with islets of non-pregnant mice, and also in islets from the
ligated part of the pancreas tail after PDL vs after sham
treatment (data not shown). Thus, under both conditions,
PW1 levels inversely correlated with the beta cell proliferation
index (Fig. 2b, c).
To determine whether PW1 plays an active role in control-
ling the beta cell cycle, we investigated loss ofPw1 function in
mice derived from a cross between PgkCre mice and a novel
conditional Pw1 allele that we generated, Pw1+/lox. Offspring
from these crosses were bred onto a C57BL/6 background for
at least seven generations and the Cre allele was then elimi-
nated to generate a constitutive PW1-null mutant mouse in
which part of Pw1 exon 8 and the entire coding domain of
exon 9 were deleted. These Pw1-null mutant mice, hereafter
called Pw1+/pat−, are viable but show a 20% postnatal growth
reduction [23]. The pancreases of 8-week-old Pw1+/pat− mice
lacked PW1 (ESM Fig. 2a) but showed no evidence of gross
anatomical abnormalities, exhibited normal cellular architec-
ture in both endocrine and exocrine compartments, and had
normal expression patterns of endocrine (PDX1, INS and
GCG) and exocrine (amylase and CK19) cell markers (ESM
Fig. 2b). However, we noted that the percentage of Ki67+ beta
cells was significantly increased in Pw1-null mutant mice
compared with their wild-type littermates (Fig. 2d).
Remarkably, we did not detect a difference in the levels of
DNA damage marker γ-H2aX foci between the two groups
(Fig. 2e), suggesting that the higher number of cycling beta
cells is not a consequence of increased beta cell death. On the
other hand, the total beta cell volume was not increased in
pancreas of Pw1+/pat− mice, suggesting that the cell cycle is
activated but not completed in beta cells of Pw1-null mutant
mice.
Beta cell specificity of this phenomenon was examined in
Pw1+/lox mice crossed with Ptf1aCre mice, which express Cre
recombinase under the control of the pancreas transcription
factor 1a gene (Ptf1a) promoter and hereafter are called
Ptf1aCrePw1+/pat− mice. Notably, the Ptf1a promoter is acti-
vated in most, but not all, of the early pancreas progenitor
(PDX1+) cells at E9.5 (ESM Fig. 2c, upper panels), and is
essential for pancreas specification and function in both mice
and humans [15]. Recombination efficiency in the adult beta
cells of Ptf1aCrePw1+/pat− mice was 71±14% (n=3). PW1
was expressed in PDX1+ cells and thus also in PTF1A+ cells
from wild-type mice (ESM Fig. 2c, lower panels). The
pancreases of Ptf1aCrePw1+/pat− mice developed normally
and showed normal architecture and cell composition
(data not shown). However, there was a twofold increase in
Fig. 1 Biphasic expression pattern of PW1 during pancreatic develop-
ment. (a) Expression of PW1 (red), PDX1 (green) and GCG (blue) in the
pancreases of E9.5 and E11.5 mice. White arrows indicate GCG+ PW1+
cells. Scale bars 100 μm. (b, c) Relative amounts of GCG+ and INS+ cells
that express PW1 at E14.5, E17.5 and P1 (n= 3, mean ± SEM, *p< 0.05,
**p< 0.01, ***p< 0.001; one-way ANOVA). (d) Expression of PW1
(red) in the adult pancreas (INS, green; GCG, blue). Scale bars 50 μm
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the number of Ki67+ PDX1+ or INS+ cells in the pancreases of
8-week-old Ptf1aCrePw1+/pat− mice compared with their
wild-type littermates (Fig. 2f). Further, the fraction of Ki67+
beta cells that did not express PW1was significantly increased
(Fig. 2g), demonstrating that actively cycling beta cells are
mostly negative for PW1. As Ptf1a is not expressed in all
pancreatic progenitor cells [15], Pw1 was not deleted from
the entire progenitor population, and consequently the entire
beta cell population, leading to underestimation of the effect
of PW1 on beta cell cycling.
To confirm a direct role for PW1 in beta cell cycling, its
expression was downregulated by transduction of beta cells
with recombinant lentiviruses expressing either a short hairpin
(sh)RNA that specifically targets mouse Pw1 (LeShPw1) or a
control sequence (LeShCTR), together with green fluorescent
protein. Infection efficiency at a multiplicity of infection of
100 was at least 65%, and the level of PW1 protein was
efficiently reduced in LeShPw1- compared with LeShCTR-
transduced cells (ESM Fig. 2d). After 7 days in culture, the
number of Ki67+ LeShPw1-transduced beta cells had
increased 1.5-fold compared with Ki67+ LeShCTR-
transduced beta cells (Fig. 2h). Taken together, our data
demonstrate that downregulation of PW1 triggers cell cycle
initiation in beta cells.
Discussion
The present study reports the expression pattern of PW1 in the
developing, postnatal and adult pancreas both under healthy
conditions and after injury. Our analyses revealed that PW1
co-localises with PDX1 in E9.5 pancreatic buds. At later
stages, the expression of PW1 became progressively restricted
to pro-endocrine cells, and ultimately to the islets of
Langerhans after birth. PDX1, a homeodomain transcription
factor necessary for normal development of the pancreas [24],
is transiently downregulated during pancreatic lineage speci-
fication, and the same spatiotemporal expression pattern is
Fig. 2 PW1 expression inversely correlates with beta cell cycling. (a)
Percentage of cycling (Ki67+) PW1− INS+ cells out of the total number of
cycling PDX1+ cells at E14.5, E17.5 and P1. (b) Percentage of cycling
PW1− PDX1+ cells at gestational day 15 (G15) out of the total number of
cycling PDX1+ cells comparedwith non-pregnant (NP)mice (n= 3, mean
± SEM, *p< 0.05; Student’s t test). (c) Percentage of cycling PW1− INS+
beta cells out of the total number of cycling beta cells in controls (Ctrl) or
the ligated (tail, white bars) and unligated (head, black bars) parts of PDL
pancreases (n = 3, mean ± SEM, **p < 0.01, ***p < 0.001; one-way
ANOVA). (d) Percentage of cycling beta cells out of the total number
of beta cells in Pw1+/pat− mice (n = 3, mean ± SEM, ***p < 0.001;
Student’s t test). (e) Percentage of γ-H2aX+ cells out of the total number
of beta cells in wild-type and Pw1+/pat− mice. (f) Percentage of cycling
beta cells out of the total number of beta cells in wild-type and
Ptf1aCrePw1+/pat− mice (n= 3, mean ± SEM, *p< 0.05; Student’s t test).
(g) Percentage of cycling PW1− beta cells out of the total number of
cycling beta cells in wild-type and Ptf1aCrePw1+/pat− mice (n = 3, mean
± SEM, **p< 0.01; Student’s t test). (h) Percentage of cycling INS+ cells
out of the total number of INS+ cells in islet cells either uninfected or
transduced with LeShCTR or LeShPw1 (n= 3, mean ± SEM, *p< 0.05;
one-way ANOVA)
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seen for PW1. Following endocrine cell specification, PW1
levels increased but only in differentiated endocrine cells. This
biphasic pattern of expression is also observed for other key
pancreatic transcription factors, including PDX1 [25].
Previous studies have shown that PW1 is found in a wide
array of bona fide adult somatic stem/progenitor cells,
including those of bone marrow, skin, bone and muscle [12].
Ongoing studies in other tissues show that when PW1 func-
tion is lost, the progenitors continue to expand rapidly but fail
to self-renew, ultimately resulting in a net loss of progenitor
cells and a failure to maintain regenerative capacity.
Therefore, the expression of PW1 in beta cells is unusual
because these cells are fully differentiated and are consequent-
ly not considered to represent a stem cell compartment [26].
Nevertheless, since PDX1 is not only necessary for pancreas
specification but also essential for adult beta cells [27] and
since PW1 controls the cycling of other cell types [10, 28],
we investigated whether PW1 affects beta cell cycling in the
embryonic and postnatal pancreas. During pancreatic devel-
opment, a gradual increase of the number of PW1+ INS+ cells
coincides with a decrease in the beta cell proliferation rate.
The number of actively cycling beta cells is decreased in adult
compared with neonatal mice, which contain fewer PW1+
cells. Previous reports revealed that PW1 acts as a p53 medi-
ator through direct interaction with the Siah1 protein to control
the cell death pathway and regulate cell cycle arrest via inter-
action with TNF receptor-associated factor 2 (TRAF2) and
Bcl2-associated X (BAX) [10]. Although beta cells respond
to stress, we found that the major role of PW1 is to restrain the
endocrine cell cycle, a finding that has not previously been
reported for primary adult differentiated cells. In addition,
conditions that stimulate beta cell proliferation such as preg-
nancy and pancreatic injury correlated with a decrease in PW1
expression, further supporting a role for PW1 as a negative
regulator of the beta cell cycle. Consistent with this proposed
role, we observed that loss of PW1 function in mutant mice
resulted in significant activation of the beta cell cycle postna-
tally compared with their wild-type littermates. However, in-
creased beta cell cycling did not result in an increased total
beta cell volume, suggesting that PW1 might prime beta cells
for proliferation by allowing G1 phase entry, while additional
constraints control the continuation and completion of the cell
cycle, thus preventing an increase in cell number. Moreover, a
shRNA-mediated decrease in PW1 expression in isolated islet
cells led to an increased number of actively cycling beta cells.
These observations are consistent with the reported function
of PW1 in mesoangioblast and glioma cell proliferation and
the presence of a specific recognition sequence for PW1
within the cyclin E promoter [6, 28].
Taken together, these findings show that PW1 controls
initiation of the beta cell cycle both in vivo and in vitro
under different physiological and experimental conditions.
Future studies to investigate the role of PW1 as a negative
regulator of the beta cell cycle may reveal it to be a novel
therapeutic target for increasing the number of endogenous
beta cells.
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